Showing results (211-220 of 16,798) with videos related to

Sort By:
Pageof 1,680
British Journal of Haematology|March 21, 2012
Mini-BEAM is effective as a bridge to transplantation in patients with refractory or relapsed Hodgkin lymphoma who have failed to respond to previous lines of salvage chemotherapy but not in patients with salvage-refractory DLBCLSally Moore, Irfan Kayani, Karl Peggs, et al.
British Journal of Haematology|December 31, 2013
G6PD deficiency: a classic example of pharmacogenetics with on-going clinical implicationsLucio Luzzatto, Elisa Seneca
British Journal of Haematology|November 26, 2013
Autologous stem cell transplant is an effective therapy for carefully selected patients with AL amyloidosis: experience of a single institutionVictor H Jimenez-Zepeda, Norman Franke, Donna E Reece, et al.
British Journal of Haematology|July 5, 2014
Platelet count doubling after the first cycle of azacitidine therapy predicts eventual response and survival in patients with myelodysplastic syndromes and oligoblastic acute myeloid leukaemia but does not add to prognostic utility of the revised IPSSAmer M Zeidan, Ju-Whei Lee, Thomas Prebet, et al.
British Journal of Haematology|November 1, 1990
Correlation of chromosome abnormalities with laboratory features and clinical course in B-cell chronic lymphocytic leukaemiaD G Oscier, J Stevens, T J Hamblin, et al.
British Journal of Haematology|November 1, 1990
Alpha-2a-interferon/melphalan/prednisone versus melphalan/prednisone in previously untreated patients with multiple myelomaA Montuoro, L De Rosa, A De Blasio, et al.
British Journal of Haematology|November 1, 1990
Measurement of fibrinogen binding to platelets in whole blood by flow cytometry: a micromethod for the detection of platelet activationT E Warkentin, M J Powling, R M Hardisty
British Journal of Haematology|May 30, 2012
Perifosine plus lenalidomide and dexamethasone in relapsed and relapsed/refractory multiple myeloma: a Phase I Multiple Myeloma Research Consortium studyAndrzej J Jakubowiak, Paul G Richardson, Todd Zimmerman, et al.
British Journal of Haematology|June 8, 2012
Impact of rituximab on treatment outcomes of patients with diffuse large b-cell lymphoma: a population-based analysisLinda Lee, Michael Crump, Sara Khor, et al.
British Journal of Haematology|April 19, 2012
A rare fraction of drug-resistant follicular lymphoma cancer stem cells interacts with follicular dendritic cells to maintain tumourigenic potentialChung-Gi Lee, Bikul Das, Tara L Lin, et al.
Pageof 1,680